Clinical Trial Update: A2R and Ectonucleotidases Expression in Lung Cancer Circulating Tumor Cells

View source ↗

Summary

A clinical trial evaluating A2R and ectonucleotidases expression in circulating tumor cells from non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Non Small Cell Lung Cancer | Status: WITHDRAWN